Clinical Trial – New Technologies to Determine Carotid Plaque Vulnerability – Artery plaque

The researchers are trying to determine if the characterization of “vulnerable” carotid artery plaques can be accomplished with ultrasound-based methods that look for vessels in the plaque and measure the plaque stiffness.All participants will receive a one time Carotid contrast-enhanced Ultrasound (CEUS) examination that may take 30-60 minutes. Follow up calls will be made to the Participants at 6, 12 ,24 and 36 months to ask about occurrence of major adverse cardiovascular events.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 80 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: New Technologies to Determine Carotid Plaque Vulnerability: A Pilot Study to Assess Contrast-Enhanced Ultrasound (CEUS) and Shear Wave Elastography (SWE) in Patients With Significant Carotid Plaques
Actual Study Start Date  : November 15, 2017
Estimated Primary Completion Date  : December 2018
Estimated Study Completion Date  : December 2018
Contacts
Contact: Matthew W Urban, Ph.D. 507-538-1522 Urban.Matthew@mayo.edu
Locations
United States, Minnesota
Mayo Clinic in Rochester Recruiting
Rochester, Minnesota, United States, 55905
Contact: Matthew W Urban, Ph.D.    507-538-1522    Urban.Matthew@mayo.edu
Principal Investigator: Matthew W Urban, Ph.D.

 

ClinicalTrials.gov Identifier: NCT03335033

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.